01 1Natco Pharma
01 1GEFITINIB
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-04
Pay. Date : 2018-08-10
DMF Number : 32409
Submission : 2018-07-24
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is GEFITINIB, with a corresponding US DMF Number 32409.
Remarkably, this DMF maintains an Active status since its submission on July 24, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2018, and payment made on August 10, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
